Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Xu, Hao  [Clear All Filters]
2024
Hu Z, Yang F, Xiang P, Luo Z, Liang T, Xu H. Effect of polydimethylsiloxane surface morphology on osteogenic differentiation of mesenchymal stem cells through SIRT1 signalling pathway. Proc Inst Mech Eng H. 2024:9544119241242964.
Bi Z, Wang T, Wang X, Xu H, Wu Y, Zhao C, Wu Z, Yu J, Zhang L. FpPEX5 and FpPEX7 are involved in the growth, reproduction, DON toxin production, and pathogenicity in Fusarium pseudograminearum. Int J Biol Macromol. 2024:132227.
Chen T, Xie Q, Tan B, Yi Q, Xiang H, Wang R, Zhou Q, He B, Tian J, Zhu J, et al. Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation. Inflammation. 2024.
Deng H, Chen Y, Liu H, Wang L, Xu H, Tan B, Yi Q, Wang R, He B, Tian J, et al. Study of the effect of keap1 on oxidative stress in human umbilical cord mesenchymal stem cells. Mol Biol Rep. 2024;51(1):67.
Gao Z, Guo C, Xiang S, Zhang H, Wang Y, Xu H. Suppression of MALAT1 promotes human synovial mesenchymal stem cells enhance chondrogenic differentiation and prevent osteoarthritis of the knee in a rat model via regulating miR-212-5p/MyD88 axis. Cell Tissue Res. 2024.
Zhou J, Xu H, Li X, Liu H, Sun Z, Li J, Tang Y, Gao H, Zhao K, Ding C, et al. Targeting tumorous Circ-E-Cadherinencoded C-E-Cad inhibits the recruitment and function of breast cancer-associated myeloid-derived suppressor cells. Pharmacol Res. 2024:107204.
2023
Sun Y, Xu H, Tan B, Yi Q, Liu H, Tian J, Zhu J. Andrographolide-treated bone marrow mesenchymal stem cells-derived conditioned medium protects cardiomyocytes from injury by metabolic remodeling. Mol Biol Rep. 2023.
Deng S, Du J, Gale RPeter, Wang L, Zhan H, Liu F, Huang K, Xu H, Zeng H. Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia. Leukemia. 2023.
Ma D, Zhang H, Yin L, Xu H, Wu L, Shaji R, Rezai F, Mulla A, Kaur S, Tan S, et al. Human iPSC-derived endothelial cells promote CNS remyelination via BDNF and mTORC1 pathway. Glia. 2023.
Stepanov YV, Golovynska I, Ostrovska G, Pylyp L, Dovbynchuk T, Stepanova LI, Gorbach O, Shablii V, Xu H, Garmanchuk LV, et al. Human mesenchymal stem cells increase LLC metastasis and stimulate or decelerate tumor development depending on injection method and cell amount. Cytometry A. 2023.
Wang Y-J, Zheng Y, Cong L, Wang P, Zhao L, Xing L, Liu J, Xu H, Li N, Zhao Y, et al. Lymphatic platelet thrombosis limits bone repair by precluding lymphatic transporting DAMPs. Res Sq. 2023.
Zhang Y, Zhu J, Xu H, Yi Q, Yan L, Ye L, Zhang X, Tan B. [The off-target effects of dynamin inhibitor Dyngo-4a during the internalization of dextran by bone marrow mesenchymal stem cells in rat]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023;39(1):57-62.
Liu H, Sun Y, Xu H, Tan B, Yi Q, Tian J, Zhu J. PTEN-induced putative kinase 1 regulates mitochondrial quality control and is essential for the maturation of human induced pluripotent stem cell-derived cardiomyocytes. Genes Dis. 2023;10(5):2151-2166.
Liu H, Wang L, Xu H, Tan B, Yi Q, Deng H, Chen Y, He B, Tian J, Zhu J. Quantitative proteomic and phosphoproteomic analysis reveal the relationship between mitochondrial dysfunction and cytoskeletal remodeling in hiPSC-CMs deficient in PINK1. J Transl Med. 2023;21(1):581.
Fan Y, Gao Z, Xu J, Wang H, Guo Q, Li B, Li M, Xu H, Qi Y, Zhao S, et al. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages. Theranostics. 2023;13(10):3310-3329.
2022
Sun Y, Xu H, Tan B, Yi Q, Liu H, Chen T, Xiang H, Wang R, Xie Q, Tian J, et al. Andrographolide protects bone marrow mesenchymal stem cells against glucose and serum deprivation under hypoxia via the NRF2 signaling pathway. Stem Cell Res Ther. 2022;13(1):326.
Zhang X-D, Sun S-L, Wang G, Li X-L, Yao L-J, Xu H, Zhang P, Shen L. [Protective effects of estrogen modified hBMSC on HG-induced injury of vascular endothelial cells]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2022;38(4):289-294.
Chai C, Ji P, Xu H, Tang H, Wang Z, Zhang H, Zhou W. Targeting cancer drug resistance utilizing organoid technology. Biomed Pharmacother. 2022;158:114098.
2021
Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021.
2020
Xu H, Yang Y, Yan J, Huang D, Liu X. Parotitis due to Burkholderia cepacia Infection after Autologous Hematopoietic Stem Cell Transplantation. Transpl Infect Dis. 2020:e13374.
2018
Tu Z, Zhao H, Li B, Yan S, Wang L, Tang Y, Li Z, Bai D, Li C, Lin Y, et al. CRISPR/Cas9-mediated disruption of SHANK3 in monkey leads to drug-treatable autism-like symptoms. Hum Mol Genet. 2018.
2016
Liu X, Xu H, Kou J, Wang Q, Zheng X, Yu T. MiR-9 promotes osteoblast differentiation of mesenchymal stem cells by inhibiting DKK1 gene expression. Mol Biol Rep. 2016.
2015
Xu H, Shen L, Chen X, Ding Y, He J, Zhu J, Wang Y, Liu X. mTOR/P70S6K promotes spermatogonia proliferation and spermatogenesis in Sprague Dawley rats. Reprod Biomed Online. 2015.
2014
Miao Z-F, Zhao T-T, Wang Z-N, Xu Y-Y, Mao X-Y, Wu J-H, Liu X-Y, Xu H, You Y, Xu H-M. Influence of different hypoxia models on metastatic potential of SGC-7901 gastric cancer cells. Tumour Biol. 2014.